Direxion Daily S&P Biotech Bull 3X ETF (NYSEARCA:LABU) Shares Down 6.9% – Time to Sell?

Posted by Donna Armstrong on Nov 2nd, 2026

Direxion Daily S&P Biotech Bull 3X ETF (NYSEARCA:LABU – Get Free Report) traded down 6.9% during trading on Monday. The stock traded as low as $233.19 and last traded at $230.1310. Approximately 120,641 shares were traded during mid-day trading, a decline of 77% from the average session volume of 534,939 shares. The stock had previously closed at $247.22.

Direxion Daily S&P Biotech Bull 3X ETF Trading Down 6.6%

The stock’s fifty day moving average is $261.20 and its 200 day moving average is $216.43.

Institutional Trading of Direxion Daily S&P Biotech Bull 3X ETF

Several large investors have recently modified their holdings of the business. Halbert Hargrove Global Advisors LLC bought a new position in shares of Direxion Daily S&P Biotech Bull 3X ETF during the third quarter valued at approximately $266,000. Revere Asset Management Inc purchased a new position in Direxion Daily S&P Biotech Bull 3X ETF during the 2nd quarter valued at $666,000. Valued Retirements Inc. purchased a new position in Direxion Daily S&P Biotech Bull 3X ETF during the 2nd quarter valued at $454,000. Finally, Ramsey Quantitative Systems bought a new position in Direxion Daily S&P Biotech Bull 3X ETF in the 2nd quarter worth $41,000.

Direxion Daily S&P Biotech Bull 3X ETF Company Profile

(Get Free Report)

The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.